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Sulfur-containing tyrosine analogs such as 4-S-cysteami-
nylphenol (4-S-CAP) and its N-acetyl derivative, N-
acetyl-4-S-CAP, are tyrosinase substrates and can cause
selective cytotoxicity or cell death of melanocytes and
melanoma cells. It is not clear, however, if the cytotoxicity
derives from a cytostatic or cytocidal effect. The latter
can also be either apoptotic or necrotic. This paper
summarizes our attempt to clarify the nature of melano-
cytotoxicity and cell death by using a new derivative of
4-S-CAP, N-propionyl-4-S-CAP (NPr-CAP). The i.p.
administration of NPr-CAP caused marked depigmenta-
tion of black hair follicles in C57 mice. At 12 h postadmin-
istration of NPr-CAP, follicular melanocytes showed
histochemical and morphologic features indicative of
apoptosis by TdT-mediated dUTP-biotin nick end
labeling (TUNEL) staining and electron microscopy. The
agarose gel electrophoresis of DNA from drug-treated
Tyrosinase is a bifunctional enzyme that catalyzes twosteps of melanin synthesis, i.e., hydroxylation of tyrosineto dopa and subsequent oxidation of dopa to dopaqui-none. This metabolic pathway is unique to melanocytesand is highly activated in many melanocytic pigmentary
diseases (e.g., melasma) and tumors (e.g., melanoma) of the skin. After
tyrosinase-mediated oxidation, dopaquinone is converted to form
melanin through several steps of nonenzymic and enzymic reactions
(Jimbow et al, 1993). Tyrosinase-related proteins (TRP) are the major
enzymes involved in this post-tyrosinase melanin synthesis pathway
(Jimbow et al, 1994). It has been shown that melanin per se, if
overproduced, is toxic to melanocytes and melanoma cells, and may
even kill them (Jimbow et al, 1974). This melanogenesis-associated
cytotoxicity primarily derives from tyrosinase-mediated formation of
orthoquinone (dopaquinone) as an intermediate (Jimbow et al, 1992;
Reszka and Jimbow, 1993). The quinoid nature of melanin inter-
mediates and their polymers can promote the oxidation of some
compounds and the reduction of others, including formation of toxic
free radicals (Fig 1). Under normal conditions, the melanocyte has
machinery to overcome this oxidative stress. This includes the contain-
ment of the process inside the melanosome and the interaction with
lysosome-associated membrane proteins (Jimbow et al, 1994); however,
the antioxidant defense might break down under conditions such as
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melan a2 cells, an immortal melanocyte line of C57 black
mice, showed the nucleosomal DNA ladder pattern. NPr-
CAP caused irreversible cytotoxicity in melan a2 and the
effect was inhibited by a tyrosinase inhibitor, phenylthi-
ocarbamide. The tyrosinase-mediated cytotoxicity of
NPr-CAP was further confirmed by the decreased viabil-
ity of COS 7 monkey-kidney cells, which expressed a
level of high tyrosinase activity through transfection
of human tyrosinase cDNA. NPr-CAP, however, also
transiently inhibited the proliferation of melan c cells, a
control tyrosinase-negative albino melanocyte line, and
vector-transfected COS 7 cells. Thus, the major process
of NPr-CAP-mediated melanocytotoxicity involves cyto-
cidal apoptosis associated with active tyrosinase. In addi-
tion, there is transient, nontyrosinase-mediated cytostatic
cytotoxicity. Key words: N-propionyl-4-S-cysteaminylphenol/
phenolic thioether amine/oxidative stress. Journal of Investigative
Dermatology Symposium Proceedings 4:130–136, 1999
highly increased rates of melanogenesis and administration of excess
amounts of substrate analogs into the melanin synthesis pathway (Luo
et al, 1994). The ensuing cytotoxic action of the reactive species will
lead to melanocyte destruction. We reasoned therefore that effective
melanocytotoxic agents can be created by incorporating sulfur into a
tyrosine homolog (phenol), which will be selectively taken up by
melanocytes and exposed to tyrosinase. The incorporation of sulfur
into phenol derives from the assumptions (a) that sulfur may increase
the uptake of the compound into the cells by virtue of increased
lipophilicity, and (b) that it may make the compound a better substrate
for tyrosinase. Accordingly, we have synthesized a number of phenolic
thioethers and phenolic thioether amines (Ito et al, 1987; Miura
et al, 1987).
The initial compound, 4-S-cysteaminylphenol (4-S-CAP), was found
to be a potent depigmenting agent of black skin and black hair follicles
of experimental animals after topical application, or intraperitoneal
administration (Ito et al, 1987a; Ito & Jimbow, 1987). It was, however,
found to be the substrate of both tyrosinase and plasma monoamine
oxidase (Padgette et al, 1984; Pankovich et al, 1990; Inoue et al,
1990). Therefore it may affect the central nervous system when it is
administered i.v. and metabolized by plasma monoamine oxidase. A
new N-acetyl derivative of 4-S-CAP, N-acetyl-4-S-CAP (NAc-CAP),
was developed. It was a better substrate of tyrosinase than 4-S-CAP,
and not a substrate of plasma monoamine oxidase (Miura et al, 1990;
Pankovich et al, 1990). It has been shown to possess significant
melanocytotoxicity and depigmenting potency after topical and systemic
administration (Jimbow, 1991; Wong and Jimbow, 1991; Alena et al,
1995). There was concern, however, about deacetylation of NAc-
CAP to produce 4-S-CAP after systemic administration (Alena et al,
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Figure 1. Oxidative stress during melanogenesis tyrosinase.
1990). To obtain a better melanocytotoxic and depigmenting agent,
we have recently synthesized an N-propionyl derivative of 4-S-CAP,
N-propionyl 4-S-CAP (Tandon et al, 1999) (NPr-CAP), which is
chemically more lipophilic and cytotoxic, and more stable than 4-S-
CAP and NAc-CAP (Tandon et al, 1999). It is hence expected to
possess better penetrating potency as well as more potent cytotoxicity
for melanocytes than 4-S-CAP and NAc-CAP.
Our initial screening of cytotoxicity of NPr-CAP showed marked
cytotoxicity for melanoma cells by in vitro MTT assay and some
antimelanoma effect in an in vivo survival-time experiment (Tandon
et al, 1999). This study further clarifies the selectivity and biologic
action of NPr-CAP. Specifically, we are interested in identifying if the
melanocytotoxicity derives from a necrotic or an apoptotic process.
Furthermore, we wish to clarify to what extent this melanocytotoxicity
is related to melanogenesis, i.e., tyrosinase-dependent reaction.
MATERIALS AND METHODS
Animals C57BL/6 J Jcl black adult mice (7–8-wk-old females) and pregnant
mice were purchased from CLEA Japan (Saitama, Japan) and maintained at our
research animal facility. Newborn mice (3 d old) were obtained from the
pregnant females.
Chemical amine N-Propionyl-4-S-cysteaminylphenol (NPr-CAP) was
synthesized by our laboratory (Tandon et al, 1999). It is chemically stable even
at 100°C. For the in vivo study, NPr-CAP was dissolved in warmed normal
saline solution, supplemented with 7.3% propylene glycol at the concentration
of 30 mM, and sterilized by filtration. For the in vitro study, it was dissolved in
warmed RPMI 1640 (Bio Whittaker, Walkersville, MD) or Dulbecco’s modified
Eagle’s medium and sterilized by filtration.
Kinetics of tyrosinase for NPr-CAP, Km, and Vmax were measured as
described previously (Miura et al, 1987; Jimbow et al, 1995).
Cell lines and culture Two cell lines of immortal murine melanocytes were
used: melan a2 and melan c. They were kindly supplied by Dr. D.C. Bennett,
London, UK. They were grown following previously described methods in
the presence of phorbol-12-myristate-13-acetate (PMA, Calbio-Chem, San
Diego, CA) (Bennett et al, 1989; Sviderskaya et al, 1995). COS 7 monkey
kidney cells were transfected with human tyrosinase cDNA [COS 7(Tyr)],
following our previously reported method (Toyofuku et al, 1999), using MOCK
vector alone as a control.
The melanocytes were cultured following the method described previously
(Miura et al, 1987; Jimbow et al, 1995; Ota et al, 1998). COS 7 and COS
7(Tyr) cells were grown in Dulbecco’s modified Eagle’s medium as described
previously (Toyofuku et al, 1999). One day prior to NPr-CAP exposure for
any assay, exponentially grown cells were harvested, seeded, and cultured. The
medium for melanocyte culture was supplemented with fetal calf serum,
penicillin, and streptomycin, but no PMA. The medium was then replaced by
a medium containing specific concentrations of NPr-CAP. The cells were
incubated for 24 h under the same conditions for all assays.
In vivo drug treatment Hair follicles of six adult mice were plucked manually
from the lumbar area as described previously (Ito and Jimbow, 1987). Seventy-
two hours after plucking, the mice were given i.p. NPr-CAP [1.5 mmol per
kg of body weight (BW)] or normal saline solution (50 ml per kg of BW) for
12 consecutive days. They were kept alive to observe the development of
white hair follicles. The newborn mice were given NPr-CAP (1.5 mmol per
kg of BW) or normal saline solution (50 ml per kg of BW) by either single or
repeated (for three consecutive days) i.p. injection. Five newborn mice were
sacrificed for electron microscopic and histochemical examinations at 4, 12, or
16 h following a single i.p. injection. Specimens of skin and hair follicles were
obtained from the lumbar area. The remaining five mice were kept alive to
observe the color changes of growing hair follicles.
Microscopic preparation Some biopsied specimens were processed for
electron microscopic observation as described previously (Sugiyama and Kukita,
1976). The others were fixed in 4% paraformaldehyde solution and embedded
in paraffin. After deparaffinization, terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP-biotin nick end labeling (TUNEL) was performed using the
MEBSTAIN Apoptosis kit (Medical & Biological Laboratories, Nagoya, Japan)
to identify apoptotic cells by fluorescent microscopy.
Tyrosinase activity Tyrosinase activity of melan a2, melan c, COS 7, and
COS 7(Tyr) cells was measured as described previously (Ota et al, 1998).
DNA extraction and gel electrophoresis Cells were seeded at a density
of 5–10 3 104 cells per cm2. After exposure to NPr-CAP, the adhering and
detached cells were harvested separately for DNA extraction. Cell suspensions
were lyzed in 10 mM Tris-HCl buffer (pH 7.4) containing 1.0% Triton X-100
(Boehringer Mannheim, Laval, Quebec) and 10 mM EDTA for 20 min at 4°C,
and were centrifuged at 13 000 3 g for 30 min. The removed supernatant was
incubated sequentially with RNase A (400 µg per ml, Boehringer Mannheim,
Laval, Quebec) for 70 min and proteinase K (400 µg per ml, Boehringer
Mannheim) for 70 min. DNA was precipitated with 0.5 M sodium chloride in
isopropyl alcohol, dried, and suspended in a solution of 1 mM EDTA and
10 mM Tris-HCl buffer (pH 7.4). The samples were electrophoresed on 1.5%
agarose gel at 90 V. Following electrophoresis, the gel was stained with 0.5 µg
ethidium bromide per ml and photographed on a UV transilluminator. A DNA
molecular weight marker, 123 bp DNA Ladder (Gibco BRL, Life Technologies,
ON), was used for calibration.
MTT assay Cell activity and/or viability of drug-treated melan a2, melan c,
COS 7, and COS 7(Tyr) cells were examined using the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay as described pre-
viously (Mosmann, 1983). The cells were dispensed at a density of 1 3 104
cells per well within 96 well culture plates using a multichannel pipette. At the
end of the treatment with NPr-CAP, 10 µl of MTT (Sigma, St. Louis, MO)
solution (5 mg per ml in PBS) was added to each culture well and incubated
for 4 h at 37°C. Following incubation, 100 µl of 0.04 N HCl in isopropyl
alcohol was added to dissolve the MTT-formazan product. After it was
thoroughly dissolved, the absorbance at 550 nm was measured with a microplate
reader (EAR 400 AT). Cell activity/viability was expressed as the percentage
of viable cells compared with two control groups, one derived from cells grown
for 24 h without NPr-CAP in conditions otherwise identical to those of NPr-
CAP treatment, and the other from cells prior to 24 h culture without
any treatment.
For the cell proliferation assay after exposure to NPr-CAP, the cells were
dispensed at a density of 5 3 103 cells per well within 96 well culture plates.
Following treatment with NPr-CAP, one plate of each cell line was removed
from treatment. The other plate of each cell line was washed with medium
and incubated again with complete medium, which was or was not supplemented
with PMA. After 48 h of incubation, the MTT value was measured. The
subsequent procedures were identical to those described above. Cell proliferation
was expressed as the ratio of viable cells at 24 and 48 h post-treatment compared
with the NPr-CAP-exposed cells without subsequent incubation (0 h).
Trypan blue exclusion test The cell viability was also determined by using
a trypan blue exclusion test. The cells were seeded at a density of 1 3 106 cells
per 60 mm dish. After exposure to NPr-CAP for 24 h, detached and adhering
cells were harvested and suspended in PBS. One volume of 0.4% trypan blue
solution (Sigma) was added to two volumes of the cell suspension, and the
dye-excluding cells were counted using a light microscope in a hemocytometer
(n 5 3).
RESULTS
Tyrosinase kinetics of phenolic thioether amine com-
pounds Chemical structures of and tyrosinase kinetics for tyrosine
as well as 4-S-CAP and its derivatives including NPr-CAP are shown
in Fig 2. NPr-CAP possessed less affinity to tyrosinase than to NAc-
CAP, but reacted fastest to tyrosinase among all the chemicals tested.
This indicated that NPr-CAP was more abundantly available for
tyrosinase reaction than tyrosine, 4-S-CAP or NAc-CAP.
Visible color changes of hair follicles after NPr-CAP
administration Repeated administration of NPr-CAP for 12 con-
secutive days to adult C57 mice resulted in complete depigmentation
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Figure 2. Comparison of chemical structure and
tyrosinase kinetics of NPr-CAP with other phenolic
thioether amines. Although the data shown is based
upon the kinetics using mushroom tyrosinase, a mother
compound, 4-S-CAP, was also shown to be a substrate
for mammalian tyrosinase using mouse melanoma tissue
(Mimura et al, 1987; Jimbow, 1991).
Figure 3. Gross appearances of hair follicles after administration of
NPr-CAP. NPr-CAP-treated adult mice. Repeated administration of NPr-
CAP for 12 consecutive days caused a marked depigmentation of black hair
follicles at the site of hair-plucking in adult mice. These depigmented hair
follicles were completely replaced by the black hair follicles by 6 mo after
treatment of NPr-CAP.
of new hair follicles, which were synchronized to grow in the anagen
phase. The control follicles grown at the site where hair plucking was
carried out possessed active tyrosinase activity (Fig 3). The growth of
these depigmenting hair follicles and the development of the animals
(e.g., body weight) were not different from those of the control mice
(data not shown). The findings suggested that the whitening of hair
follicles caused by NPr-CAP treatment occured through the selective
disintegration of melanocytes in the hair bulb. These possessed high
activity of tyrosinase and were highly engaged in active synthesis of
melanin pigment. One month later in the subsequent hair cycle, black
hair follicles began to grow and completely replaced depigmented ones
in 6 mo, indicating that the whitening of hair follicles was reversible.
This finding of reversible depigmentation suggests that there may be
precursor melanocytes or melanocyte reservoirs that are not affected
by NPr-CAP and that supply functioning melanocytes in the hair bulb
in the subsequent hair cycle. In the experiment using a single i.p.
injection of NPr-CAP to newborn mice, the coats of each mouse was
found to consist of a mixture of white and black hair follicles. The
coat of newborn mice injected with NPr-CAP for three consecutive
days had many more depigmented hair follicles than those of mice
with a single NPr-CAP injection. The finding may indicate that NPr-
CAP-mediated depigmentation is dose-dependent. Similar to the
experiments using adult mice, depigmented hair follicles of the newborn
mice were replaced by black ones at 6 wk of the new hair cycle. The
newly grown hair follicles were not depigmented in the subsequent
hair cycle.
Electron microscopic findings of follicular melanocytes after
NPr-CAP treatment Follicular melanocytes showed some subtle
morphologic changes, e.g., poor dendricity, but without any obvious
degenerative changes, at 4 h after a single administration of NPr-
CAP. Interestingly, however, electron-dense materials were deposited
selectively on the Golgi cisternae of the melanocytes (Minamitsuji et al,
1998). The distribution and electron opacity of the materials were
similar to those described in our previous study of NAc-CAP (Jimbow
et al, 1995), which indicated that they derived from the oxidation
product of NPr-CAP in the presence of tyrosinase. At 12 h postadminis-
tration, the poor development of melanocytic dendrites became much
more pronounced. Their nuclear chromatin showed condensation in
the periphery. In addition, several endoplasmic reticula and melanoso-
mal outer membranes were found to be dilated (Fig 4A). At 16 h
postadministration, numerous membrane-bound fragments associated
with apoptosis were observed. Some of them showed vacuolation of
endoplasmic reticula, but the fine structures of mitochondria and the
melanosomal membrane remained unaltered (Minamitsuji et al, 1998).
Most of them were phagocytosed by adjacent keratinocytes and some
showed with necrotic degeneration, i.e., secondary necrosis (Fig 4B).
These melanocytes showed selective degeneration and casting-off from
the hair bulb (Minamitsuji et al, 1998). No significant alterations were
seen in fine structures of keratinocytes and fibroblasts surrounding
degenerating melanocytes. Diffuse osmiophilic changes in the cytoplasm
of the melanocytes were observed during the entire process of
degeneration.
Identification of apoptosis using the TUNEL method As early
as 4 h after a single administration of NPr-CAP, several melanocytes
started to show positive staining at the hair bulb by the TUNEL
method (Fig 5). At 12 and 16 h after a single NPr-CAP administration,
TUNEL-positive melanocytes became much more obvious and numer-
ous. The keratinocytes surrounding TUNEL-positive melanocytes
were not stained with the TUNEL method. Similarly no TUNEL-
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Figure 4. Electron microscopic findings of sequential steps in
melanocyte degeneration after a single i.p. injection of NPr-CAP to
C57 black, new-born mice. (A) A melanocyte at 12 h postinjection, showing
condensation of nuclear chromatin, membrane swelling of melanosomes and
endoplasmic reticula, and increased electron density of cytoplasm. Fibroblasts
in the hair papilla were not affected. (B) A melanocyte at 16 h postinjection,
showing an apoptotic body with secondary necrosis. Such a change is not seen
in surrounding keratinocytes in the hair bulb. Scale bar: 1 µm.
positive cells were seen in the hair bulb of the control specimen. The
identity of TUNEL-positive cells with melanocytes was confirmed by
serial sectioning with simultaneous staining using toluidine blue.
In vitro effect of NPr-CAP on melanocytes Melan a2 cells
possessed high tyrosinase activity (0.057 6 0.007 at OD 475 nm per
mg protein per min, n 5 6), whereas melan c did not (0.000 6 0.000
at OD 475 nm per mg protein per min, n 5 6). Melan a2 and melan
c cells were treated with NPr-CAP to examine numerical and nuclear
changes after drug administration. Discrete fragments of nucleosomal
DNA corresponding to multiples of about 180 bp, which is the
characteristic pattern of apoptosis, were observed in melan a2 cells
treated with 1, 2, and 4 mM concentrations of NPr-CAP (Fig 6).
These findings corresponded to the in vivo results indicative of the
involvement of apoptosis in NPr-CAP melanocytotoxicity. Such a
change was not observed in the melan c cells.
Our present in vivo study indicated that the biologic effect of NPr-
CAP was dose-dependent and related to the presence of active
Figure 5. The detection of apoptotic cells in hair bulbs using TUNEL
method. NPr-CAP-treated newborn mouse. Melanocytes (arrowheads) of hair
bulbs started to stain positively at 4 h after a single administration of NPr-CAP
and became much more obvious at 12 h and 16 h after administration. These
TUNEL-positive, fluorescent cells are located at the ‘‘melanocytic zone’’ above
the basal lamina of the hair papilla. Control specimen did not show positive
staining. Scale bar: 30 µm.
Figure 6. Agarose gel electrophoresis of DNA from NPr-CAP-treated
melan a2 cells. All cells were exposed to NPr-CAP for 24 h. Concentrations
of the chemical used for treatment was 0 mm (lanes 2, 6), 1 mm (lanes 3, 7),
2 mm (lanes 4, 8), and 4 mM (lanes 5, 9). After drug treatment, detached cells
(lanes 2, 4, 6, 8) and adhered cells (lanes 3, 5, 7, 9) were harvested separately,
and then DNA was extracted from the cells and electrophoresed on 1.5%
agarose gel at 90 V for 70 min. The DNA molecular weight marker was 123 bp
DNA Ladder (lanes 1, 10). The ladder formations, consisting of multiples of
about 180 bp nucleosome fragment, were seen in cells treated with more than
1 mM of NPr-CAP (lanes 3–5, 7–9).
tyrosinase. To further confirm this finding in the in vitro system, we
performed MTT assay. The results clearly showed that the viability of
melan a2 cells decreased in the presence of NPr-CAP, in parallel to
the drug concentrations administered (Table I), confirming that the
cytotoxic effect of NPr-CAP on melanocytes was dose-dependent. In
addition, this cytotoxicity of NPr-CAP was inhibited by phenylthiocar-
bamide (Sigma), a tyrosinase inhibitor (Table II). The cellular activity
of melan c cells was also reduced dose-dependently; however, the
extent of the cytotoxicity was far less than that of melan a2 (Table I).
We then examined again whether NPr-CAP melanocytotoxicity
requires the presence of active tyrosinase, using tyrosinase-transfected
COS 7 (Tyr) cells. The tyrosinase activity of COS 7 (Tyr) was moderate
[0.012 6 0.001 at OD 475 nm per mg protein per min (n 5 6)],
whereas the activity of COS 7 cells was null. We found that COS 7
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Table I. Comparison of cell viability by MTT assaya among melan-a2, melan-c, and COS 7 cells with/without tyrosinase-gene
transfection after exposure to n-propionyl-4-S-cysteaminylphenol
Cell line Concentration of NPr-CAP exposed
0 mM 1 mM 2 mM 3 mM
melan a2 100.0 6 4.6b 96.7 6 4.1 76.3 6 7.5 37.1 6 2.0
(111.5 6 5.1d) (17.8 6 5.9) (85.1 6 8.3) (41.3 6 2.2)
melan c 100.0 6 5.5b 86.5 6 2.7 77.2 6 2.1 66.7 6 4.4
(145.4 6 8.0d) (125.8 6 4.0) (112.3 6 3.1) (96.9 6 6.4)
COS 7 100.0 6 8.7c 101.9 6 11.2 101.9 6 9.9 95.7 6 5.6
(189.4 6 16.5d) (192.9 6 21.2) (192.9 6 18.8) (181.2 6 10.6)
COS 7e 100.0 6 7.7c 99.4 6 8.8 88.5 6 5.2 67.4 6 4.0
(Tyr) (180.9 6 13.9d) (179.9 6 16.0) (160.0 6 9.4) (121.9 6 7.36)
aThe assay conditions and procedures for MTT assay are described in the Materials and Methods.
bThe MTT value of the cells treated without drug is used as control.
cThe MTT value of the cells prior to the treatment is used as control.
dData represent mean 6 SD (n 5 10). p , 0.0001 versus control.
eCOS7 (Tyr):COS7 cells transfected with tyrosinase cDNA.
Table II. Cell viability of melan-a2 cells exposed to
n-propionyl-4-S-cysteaminylphenol with
phenylthiocarbamide
Group Drug treatment Cell viability
I 0.0 mM NPr-CAPa 6 0.0 mM PTCBb 148.0 6 6.7%c
II 0.0 mM NPr-CAP 6 0.5 mM PTCB 144.9 6 5.6%
III 1.0 mM NPr-CAP 6 0.0 mM PTCB 74.2 6 4.5%
IV 1.0 mM NPr-CAP 6 0.5 mM PTCB 98.9 6 5.6%
aExposure to n-propionyl-4-S-cysteaminylphenol (1 mM) for 48 h at 37°C,
bPhenylthiocarbamide was dissolved in 0.05% ethanol. The cells were pretreated with
phenylthiocarbamide (0.5 mM) for 8 h.
cThe MTT value of the cells prior to the treatment is used as control. Data represent
mean 6 SD (n 5 10). p , 0.0001 versus control in group III or IV compound to group I
Table III. Comparison of cell viability by trypan blue testa
between melan-a2 and melan-c cells after exposure to
n-propionyl-4-cysteaminylphenol
Cell line Concentration of NPr-CAP exposed
0 mM 1 mM 3 mM
Melan a2 94.6 6 1.5%b 87.8 6 4.1% 10.6 6 1.2%
Melan c 96.9 6 0.2% 90.8 6 2.0% 80.2 6 7.7%
aThe assay conditions and procedures for trypan blue test are described in the Materials
and Methods.
bData represent mean 6 SD (n 5 3).
cells were not affected by NPr-CAP-treatment, whereas the viability
of COS 7 (Tyr) cells was significantly reduced (Table I). We further
examined the number of viable cells using the trypan blue exclusion
test to see if there was any difference between tyrosinase-positive
melan a2 and tyrosinase negative melan c cells after NPr-CAP treatment.
The percentage of melan a2 cells excluding trypan blue was decreased
significantly in parallel to the NPr-CAP concentration. In contrast,
the percentage of melan c cells excluding trypan blue did not show
such a significant reduction after NPr-CAP treatment. Importantly,
melan a2 cells showed a marked reduction of viable cells with only
10.6% cell viability as judged by the trypan blue exclusion test with
the drug concentration of 3 mM (Table III). Lastly, we examined
how the cell growth recovered after NPr-CAP treatment. In this
experiment, melan a2 and melan c cells were exposed first to NPr-
CAP for 24 h and then subsequently to the normal culture medium
without NPr-CAP. Furthermore, this cell growth recovery was tested
in the presence and absence of PMA in order to exclude the effect of
phorbol ester, a potent melanocyte mitogen, on cell proliferation
(Table IV). Only melan a2 cells showed a steady decline of the cell
proliferation rate (ratio of viable cells) at 48 h after complete ‘‘wash-
out’’ of NPr-CAP. In contrast, such a decline in the proliferation of
viable cells was not seen in melan c. Instead, they showed a steady
increase of viable cells after NPr-CAP ‘‘wash-out’’ (Table IV). The
decreased number of viable melan a2 cells did not recover even when
supplemented with PMA, whereas the proliferation of melan c cells
was enhanced after supplementation with PMA (Table IV).
NPr-CAP effect on tyrosinase-transfected/nontransfected COS
7 cells Our result showed that the cytocidal and cytostatic effects of
the drug on melan a2 and melan c cells, respectively, were not related
to the different cell proliferation rates of the two cell lines. Tyrosinase-
negative COS 7 cells showed, after exposure to NPr-CAP, an increasing
cell proliferation rate, whereas COS 7 (Tyr) cells did not show any
increased proliferation (Table IV). The result showed that the cytocidal
effect of NPr-CAP depended on the presence of active tyrosinase.
DISCUSSION
Melanocytotoxicity can be grouped into cytocidal and cytostatic
processes. The cytocidal process is further divided into apoptotic
and necrotic processes. Apoptosis can be distinguished from necrosis
morphologically and biochemically by characteristic morphologic and
biochemcial properties such as the condensation of nucleosomal chro-
matin, cell shrinkage (Kerr et al, 1972; Wyllie et al, 1980), and DNA
fragments (Wyllie, 1980; Peitsch et al, 1993). Apoptosis normally occurs
during the forming and developing processes of tissues and cells. It
also occurs as a result of many environmental and oxidative stresses,
such as after exposure to chemotherapeutic drugs (Borner et al,
1995; Kaufmann, 1989) or reactive oxygen species (Veis et al, 1993;
Hockenbery et al, 1993). During embryonic differentiation, melanocytes
will typically become apoptotic when the c-kit receptor is blocked or
c-Kit itself is mutated, resulting in whitening (amelanosis) of skin and
hair (Okura et al, 1995). In recent years, many apoptosis-related protein
and/or gene families have been identified. These include the bcl-2
family and tumor necrosis factor (TNF)/nerve growth factor (NGF)
receptor family. Melanocytes and melanoma cells express such
apoptosis-related proteins as Bcl-2 (Veis et al, 1993; Plettenberg et al,
1995) and Fas ligand/receptor (Hahne et al, 1996; Oishi et al, 1994).
Bcl-2 is encoded by the bcl-2 proto-oncogene and suppress apoptosis
or cell death induced by oxidizing agents (Hockenbery et al, 1993;
Kane et al, 1993; Veis et al, 1993). Fas belongs to the TNF/NGF
receptor family and its ligand/receptor system is a trigger of apoptosis
(Traut et al, 1989; Yonehara et al, 1989; Itoh et al, 1991).
Our previous in vivo studies have clearly shown that NAc-CAP and
its acetyl form (diacelyl CAP: NAP-TEA) cause selective melanocyto-
toxicity and degenerative changes, i.e., chromatin condensation of
follicular melanocytes (Alena et al, 1990; Ito and Jimbow, 1987; Wong
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Table IV. Cell proliferation rate melan-a2, melan-c, and COS 7 cells with/without tyrosinase-transfection after
n-propionyl-4-S-cysteaminylphenola
Cell line NPr-CAP exposure Medium Replaced Cell proliferation ratea
0 h 48 h
melan-a2 0 mM PMA (–)b 1.00 6 0.06 2.46 6 0.10c
3 mM PMA (–) 1.00 6 0.10 0.68 6 0.18
0 mM PMA (1)b 1.00 6 0.06 3.12 6 0.21
3 mM PMA (1) 1.00 6 0.10 0.71 6 0.14
melan-c 0 mM PMA (–) 1.00 6 0.05 1.82 6 0.04
3 mM PMA (–) 1.00 6 0.06 1.47 6 0.10
0 mM PMA (1) 1.00 6 0.05 1.94 6 0.13
3 mM PMA (1) 1.00 6 0.06 1.67 6 0.09
COS 7 0 mM None 1.00 6 0.09 2.47 6 0.35
3 mM None 1.00 6 0.06 1.20 6 0.16
COS 7 (Tyr)d 0 mM None 1.00 6 0.06 1.78 6 0.10
3 mM None 1.00 6 0.05 1.02 6 0.08
aThe assay conditions and procedures for MTT assay are described in the Materials and Methods.
b1, complete medium with PMA; –, complete medium without PMA.
cData represent mean 1SD (n 5 10). p , 0.0001 versus control.
dCOS 7 cells transfected with human tyrosinase cDNA.
and Jimbow, 1991; Jimbow et al, 1995). The fine structure of
mitochondria was, however, unaffected in the early stage of this
degenerative process (Wong and Jimbow, 1991). Our present morphol-
ogic results show that NPr-CAP causes selective apoptotic degeneration
of follicular melanocytes. Some apoptotic melanocytes were phago-
cytosed by surrounding keratinocytes, which were compatible with
the so-called ‘‘secondary necrosis.’’ The presence of apoptotic process
in melanocytes was further supported by our in vitro study using the
TUNEL method and the presence of the DNA ladder. This in vitro
apoptosis process appeared to depend, to some extent, on tyrosinase
activity in as much as it was inhibited by a tyrosinase inhibitor,
phenylthiocarbamide (see Table II).
The chemical reactions within melanocytes and the processes of
cytotoxicity after NPr-CAP treatment may be similar to those of other
4-S-CAP-derivatives. 4-S-CAP is thought to be oxidized by tyrosinase
to an o-quinone form via 4-S-cysteaminylcatechol. Then the quinones
conjugate with proteins through cysteinyl residues, thus exerting
cytotoxic effects (Ito et al, 1987b). Apoptosis finally progresses to a
common pathway that is associated with activation of DNase (Peitsch
et al, 1993); however, DNase is activated by many kinds of stress such
as reactive oxygen species (Hockenbery et al, 1993; Veis et al, 1993).
Yamada et al (1989) showed that catalase prevented the melanocytotox-
icity of 4-S-CAP and suggested that free radicals generated in the
metabolic process of 4-S-CAP are crucial for melanocytotoxicity. A
decreased intracellular concentration of reduced glutathione causes cell
death in the face of oxidative stress via the Bcl-2 mechanism (Hockenb-
ery et al, 1993; Kane et al, 1993; Hedley and McCulloch, 1996). Alena
et al, using buthionine sulfoximine, showed that the melanocytotoxicity
of NAc-CAP was enhanced by a reduction in glutathione levels and
that it was inhibited by the administration of N-acetylcysteine (Alena
et al, 1994, 1995), which is not only a precursor and upregulator of
glutathione but also an effective free radical scavenger (Aruoma et al,
1989). Thus, free radicals are associated with the melanocytotoxicity
caused by the NPr-CAP treatment. They may even trigger apoptosis.
We found, in this study, that the depigmenting effect of NPr-CAP
was restricted to newly grown hair follicles at the epilation site. Similar
results were observed in our previous studies of 4-S-CAP and NAc-
CAP, indicating that our phenolic thioether amines are effective only
in activated, functioning melanocytes. Our previous study of diacetyl
CAP (NAP-TEA) also showed the deposit of electron-dense, melanin-
like materials in the Golgi cisternae, where active tyrosinase is present.
These deposits were seen in follicular melanocytes of tyrosinase-positive
black mice, not in those of tyrosinase-negative albino mice (Jimbow
et al, 1995). The previous and present in vivo findings clearly indicate
that NPr-CAP-induced cytotoxicity is related to the presence of active
tyrosinase.
Our previous in vivo studies showed that follicular melanocytes of
albino mice were not affected by 4-S-CAP, NAc-CAP, and NAP-
TEA (Ito et al, 1987a; Jimbow et al, 1995); however, this in vitro study
showed that the proliferation of cultured murine albino melanocytes,
melan c cells, was transiently inhibited by NPr-CAP. It is not clear
how the chemical is taken up by melanocytes or whether the
intracellular influx of NPr-CAP in melanocytes is active or passive.
NPr-CAP may affect, to some extent, all types of melanocytic cells,
because NPr-CAP itself may exert transient, direct cytotoxicity through
a nontyrosinase-mediated reaction. Thus, NPr-CAP exerts a transient
cytostatic effect in vitro on albino melanocytes that do not have any
active tyrosinase; however, the permanent cytocidal effect of NPr-
CAP occurs only in those cells with active tyrosinase and melanin
synthesis, and is associated with a tyrosinase-dependent mechanism
involving apoptosis.
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